Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
Erythrodermic psoriasis (EP) is a severe form of psoriasis precipitated by numerous factors, including physical stress, infections, and drugs. The disease represents a therapeutic challenge, and little is known about its response to ustekinumab. Though the efficacy of ustekinumab has been extensivel...
Saved in:
Main Authors: | Rosita Saraceno (Author), Marina Talamonti (Author), Marco Galluzzo (Author), Andrea Chiricozzi (Author), Antonio Costanzo (Author), Sergio Chimenti (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2013-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
by: Marina Papoutsaki, et al.
Published: (2009) -
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
by: S. Signa, et al.
Published: (2019) -
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020) -
Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice
by: Clara Plana, et al.
Published: (2024) -
Infliximab in the treatment of plaque type psoriasis
by: Rosita Saraceno, et al.
Published: (2009)